Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

The aim of the study was to determine the dose-limiting toxicity and maximum tolerated dose of a first-line combination of doxorubicin and gemcitabine in adult patients with advanced soft tissue sarcomas and to explore its activity and toxicity, and the presence of possible interactions between thes...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Pousa, A, Losa, R, Martín, J, Maurel, J, Fra, J, Sierra, M, Casado, A, García del Muro, J, Poveda, A, Balañá, C, Martínez-Trufero, J, Esteban, E, Buesa, J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361345/
https://www.ncbi.nlm.nih.gov/pubmed/16721358
http://dx.doi.org/10.1038/sj.bjc.6603187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361345/
https://www.ncbi.nlm.nih.gov/pubmed/16721358
http://dx.doi.org/10.1038/sj.bjc.6603187

Ejemplares similares